share_log

8-K: Current report

8-K: Current report

8-K:重大事件
美股SEC公告 ·  2024/06/07 21:22

Moomoo AI 已提取核心信息

Cardio Diagnostics Holdings received a notice from Nasdaq on June 3, 2024, indicating non-compliance with the minimum bid price requirement, as its common stock has traded below $1.00 for 30 consecutive business days. The company has been granted a 180-day compliance period until December 2, 2024, to regain compliance.The company can regain compliance if its stock price closes at or above $1.00 for a minimum of ten consecutive business days before the deadline. If unsuccessful, Cardio Diagnostics may be eligible for an additional 180-day compliance period, provided it meets other Nasdaq Capital Market listing requirements and submits a written intention to cure the deficiency.The company is actively monitoring its stock price and considering all available options to regain compliance, including the possibility of a reverse stock split. The notice has no immediate effect on the listing or trading of the company's common stock and warrants on the Nasdaq Capital Market.
Cardio Diagnostics Holdings received a notice from Nasdaq on June 3, 2024, indicating non-compliance with the minimum bid price requirement, as its common stock has traded below $1.00 for 30 consecutive business days. The company has been granted a 180-day compliance period until December 2, 2024, to regain compliance.The company can regain compliance if its stock price closes at or above $1.00 for a minimum of ten consecutive business days before the deadline. If unsuccessful, Cardio Diagnostics may be eligible for an additional 180-day compliance period, provided it meets other Nasdaq Capital Market listing requirements and submits a written intention to cure the deficiency.The company is actively monitoring its stock price and considering all available options to regain compliance, including the possibility of a reverse stock split. The notice has no immediate effect on the listing or trading of the company's common stock and warrants on the Nasdaq Capital Market.
Cardio Diagnostics Holdings, Inc.于2024年6月3日收到纳斯达克的通知,指出其股票价格连续30天低于1.00美元的最低买盘规则不符合要求。公司有时间至2024年12月2日,有可能会获得为期180天的延期,来达到纳斯达克规定的要求。在此期间,如果该股票在至少连续业务10个交易日中收盘价为1.00美元或更高,则符合要求。公司正在考虑期权来解决这个问题,包括进行股票拆分。然而,无法保证获得符合要求或避免摘牌。公司将继续监控其股价并探索所有可用的业务解决缺陷。
Cardio Diagnostics Holdings, Inc.于2024年6月3日收到纳斯达克的通知,指出其股票价格连续30天低于1.00美元的最低买盘规则不符合要求。公司有时间至2024年12月2日,有可能会获得为期180天的延期,来达到纳斯达克规定的要求。在此期间,如果该股票在至少连续业务10个交易日中收盘价为1.00美元或更高,则符合要求。公司正在考虑期权来解决这个问题,包括进行股票拆分。然而,无法保证获得符合要求或避免摘牌。公司将继续监控其股价并探索所有可用的业务解决缺陷。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息